Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Horbinski

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Acta Neuropathologica Communications|October 21, 2018
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfallsRachel Jester, Iya Znoyko, Maria Garnovskaya, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Murine modeling of IDH-mutant 1p/19q-codeleted oligodendroglioma reveals genotype specific phenotypesIpsita G Kundu, Nicolas Toro, Aaron Y Mochizuki, et al.
Neuro-Oncology|August 2, 2024
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groupsNathan K Leclair, Abrar Choudury, William C Chen, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Journal of Neuropathology and Experimental Neurology|July 13, 2019
Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain TumorsSomak Roy, Sameer Agnihotri, Soufiane El Hallani, et al.
Science Advances|January 8, 2019
IDH3α regulates one-carbon metabolism in glioblastomaJasmine L May, Fotini M Kouri, Lisa A Hurley, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Journal for Immunotherapy of Cancer|February 9, 2023
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBMMarkella Zannikou, Joseph T Duffy, Rebecca N Levine, et al.
Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.
Brain : a Journal of Neurology|April 15, 2021
De novo purine biosynthesis is a major driver of chemoresistance in glioblastomaJack M Shireman, Fatemeh Atashi, Gina Lee, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Acta Neuropathologica Communications|October 21, 2018
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfallsRachel Jester, Iya Znoyko, Maria Garnovskaya, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Murine modeling of IDH-mutant 1p/19q-codeleted oligodendroglioma reveals genotype specific phenotypesIpsita G Kundu, Nicolas Toro, Aaron Y Mochizuki, et al.
Neuro-Oncology|August 2, 2024
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groupsNathan K Leclair, Abrar Choudury, William C Chen, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Journal of Neuropathology and Experimental Neurology|July 13, 2019
Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain TumorsSomak Roy, Sameer Agnihotri, Soufiane El Hallani, et al.
Science Advances|January 8, 2019
IDH3α regulates one-carbon metabolism in glioblastomaJasmine L May, Fotini M Kouri, Lisa A Hurley, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Journal for Immunotherapy of Cancer|February 9, 2023
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBMMarkella Zannikou, Joseph T Duffy, Rebecca N Levine, et al.
Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.
Brain : a Journal of Neurology|April 15, 2021
De novo purine biosynthesis is a major driver of chemoresistance in glioblastomaJack M Shireman, Fatemeh Atashi, Gina Lee, et al.
Pageof 9